Written by: Cellular Institute Editorial Team
Medical reviewer: Dr. Matilde Rodríguez – CP 12651081
Laboratory reviewer: Biotecnóloga Diana Navarrete – CP 15029468
Editorial Disclosure: Cellular Institute is not affiliated with Dr. Mari Dezawa, MuseCell Innovations, or the Dezawa MuseCells® commercial program. This article requires final medical and Mexican advertising-compliance review before publication.
What Are Dezawa MUSE Cells?
Patients searching for Dezawa MUSE cells often encounter several related terms that can easily become confused.
Dr. Mari Dezawa led the research group that first identified and described MUSE cells in 2010. Separately, Dezawa MuseCells® is a commercial designation used within a licensed ecosystem associated with MuseCell Innovations.
Therefore, the scientific category of MUSE cells, the branded commercial program, and independently manufactured MUSE-cell products should not be treated as interchangeable.
Understanding that distinction is important when evaluating any cellular therapy program.
Why Does the Dezawa MUSE Cell Name Create Confusion?
Patients may hear terms such as:
- MUSE cells
- Dezawa MUSE cells
- Desawa MUSE cells
- Dazawa MUSE cells
- De Sawa MUSE cells
- Desawa Mu cells
Because this field is new to many patients, the name of the researcher, the scientific cell category, the trademark, the manufacturer, and the treating clinic can easily become mixed together.
The correct spelling is Dezawa, referring to Dr. Mari Dezawa.
Search variations such as “Desawa,” “Dazawa,” “De Sawa,” and “Mu cells” usually reflect phonetic misspellings.
However, correcting the spelling does not answer the most important question:
What exactly will be administered to the patient?
Who Is Dr. Mari Dezawa?
Dr. Mari Dezawa is a physician-scientist associated with Tohoku University whose research group identified a stress-resistant, pluripotent-like cell population later described as MUSE cells.
Her work helped define several important areas of MUSE-cell research, including:
- Endogenous repair
- Cellular stress tolerance
- SSEA-3 expression
- Multilineage differentiation
- Injury-associated homing
Giving appropriate credit to the discovery does not mean that every later product containing or claiming MUSE cells was physically produced by Dr. Dezawa’s laboratory.
Scientific discoveries can lead to academic research, intellectual-property licensing, technology transfer, manufacturing partnerships, commercial brands, and different clinical programs.
MUSE Cells, CL2020 and Dezawa MuseCells® Are Not the Same Thing
Several terms appear frequently in conversations about MUSE-cell science. However, each refers to something different.
MUSE Cells
MUSE cells refer to a scientifically described stress-resistant cell population.
The term itself does not identify:
- A manufacturer
- A specific dose
- Purity
- Potency
- A clinical protocol
- A particular commercial product
Therefore, simply describing a treatment as involving MUSE cells does not provide enough information to evaluate the product.
CL2020 / Nafimestrocel
CL2020, also known as nafimestrocel, is a specific allogeneic MUSE cell-based investigational product used in Japanese clinical research.
Published research involving CL2020 applies most directly to that specific product, manufacturing process, dose, route, patient population, and clinical indication.
For that reason, evidence involving CL2020 cannot automatically establish the clinical performance of every commercial MUSE-cell product.
Dezawa MuseCells®
Dezawa MuseCells® is a licensed commercial designation associated with the MuseCell Innovations ecosystem.
A commercial brand designation is different from the general scientific category of MUSE cells.
Therefore, unaffiliated providers should not use the trademark or imply that independently produced products belong to that licensed ecosystem.
Cellular Institute MUSE-Cell Product
Cellular Institute produces a MUSE-cell product through its own cellular manufacturing operation.
It is not Dezawa MuseCells®, and Cellular Institute is not affiliated with MuseCell Innovations.
Therefore, the Cellular Institute product should be evaluated according to its own manufacturing process, laboratory controls, characterization methods, batch documentation, and medical protocol.
Patients interested in the broader science behind cellular therapies can also review our overview of stem cell therapy in Cancún.
Does One Scientific Discovery Mean One Laboratory Produces Every MUSE-Cell Product?
No.
A scientific discovery identifies and describes a biological phenomenon. Commercial production is a separate process.
Over time, a scientific discovery may lead to:
- Licensed manufacturing methods
- Authorized laboratories
- Technology-transfer agreements
- Manufacturing partners
- Distributors
- Independent research programs
- Different clinical applications
Other laboratories may also produce products they characterize using broader MUSE-cell terminology, subject to applicable scientific, intellectual-property, regulatory, and advertising requirements.
Therefore, patients should not assume that two products are identical simply because both clinics mention Dr. Dezawa or reference the same foundational research.
Published evidence applies most directly to the product, manufacturing process, dose, route, patient population, and indication actually studied.
What Does MuseCell Innovations Control?
MuseCell Innovations publicly describes itself as the licensor of the Dezawa MuseCells® commercial ecosystem.
According to its public information, products using that specific designation must originate within its authorized network.
That distinction relates to the company’s licensed brand, intellectual property, and commercial standards.
However, it does not make the broader scientific category of MUSE cells synonymous with every MCI-branded service.
Likewise, a commercial designation does not eliminate the patient’s need to evaluate the exact product, laboratory documentation, medical rationale, and clinical protocol.
Cellular Institute Disclosure
Cellular Institute is not an MCI-authorized provider and does not offer, advertise, or imply that it provides Dezawa MuseCells®.
References to Dr. Dezawa and MuseCell Innovations in this article are educational. Their purpose is to help patients distinguish between:
- The scientific discovery
- The commercial brand
- The manufacturing laboratory
- The cellular product
- The clinic administering treatment
Why Does Manufacturing Quality Matter for MUSE Cells?
Even when two products fall within the same general cell category, manufacturing variables can influence their biological characteristics.
A trademark, clinic badge, large total cell count, or celebrity endorsement should never replace batch-specific documentation.
Important manufacturing variables may include:
- Tissue source and donor eligibility
- Isolation or enrichment criteria
- Culture medium
- Animal-derived versus xeno-free components
- Oxygen concentration during expansion
- Passage number
- Population-doubling history
- Cellular identity
- Purity and cellular composition
- Viability
- Sterility
- Endotoxin testing
- Mycoplasma testing
- Functional or potency assays
- Storage conditions
- Shipping
- Thawing
- Timing between release and administration
No single laboratory characteristic proves clinical superiority.
Together, however, these variables help determine whether a clinic can clearly explain and document the product it plans to administer.
Patients can learn more about Cellular Institute’s approach to lab quality and transparency, including traceability, viability, sterility, and quality-control documentation.
How Does Cellular Institute Describe Its MUSE-Cell Product?
Cellular Institute produces a MUSE-cell product through its own cellular manufacturing operation.
The clinic does not market this product as a Dezawa product and does not claim affiliation, equivalence, or superiority to MCI products.
Instead, the clinic focuses on measurable and documentable manufacturing information.
This includes:
- In-house traceability
- Xeno-free processing
- Early-passage production
- Hypoxic incubation
- Cell count
- Viability
- Sterility
- Batch-specific documentation
- Coordination between the laboratory and medical team
Each public statement should remain limited to what Cellular Institute can document for its specific manufacturing process and individual batch.
For patients who want to better understand how quality documentation relates to cellular therapy, Cellular Institute also provides information about certified stem cells.
Can Two MUSE-Cell Products Be Compared?
Yes, but a responsible comparison requires defined methods.
For example, a meaningful laboratory comparison should:
- Clearly identify the samples
- Confirm chain of custody
- Use the same validated assay
- Define the endpoint in advance
- Use comparable sample handling
- Report limitations
Comparing an internal laboratory result from one product with a marketing statement from another provider is not enough.
Does the Product Contain a Characterized MUSE Population?
A responsible comparison requires a documented identity method and a batch-specific result.
Which Product Has Higher Viability?
The comparison should use the same measurement platform, sample handling, timing, and acceptance criteria.
Which Product Has Greater Purity?
The laboratory should define the target population in advance and use a validated assay panel.
Which Product Has Greater Potency?
The comparison requires a validated functional assay linked to a relevant biological activity.
Which Product Is Clinically Better?
Laboratory measurements alone cannot answer this question.
A meaningful clinical comparison would require condition-specific comparative human outcomes.
What Should Patients Ask When They See the Dezawa Name?
Patients researching Dezawa MUSE cells should ask several questions before assuming that a particular product belongs to the licensed commercial program.
Is the Clinic Referring to the Scientific Discovery or the Licensed Commercial Product?
The clinic should clearly distinguish between background scientific research and a branded product.
If It Is the Licensed Product, Can the Clinic Show Current Authorization?
Patients should ask for documentation confirming the provider’s authorization and the specific product being offered.
Which Laboratory Manufactured the Exact Batch?
Patients should know the legal manufacturer and location of the laboratory responsible for production.
Which Published Studies Evaluated This Product?
Research involving one MUSE-cell product should not automatically support a different product.
What Is Established for My Condition?
The physician should explain what evidence exists for the specific diagnosis and what remains investigational.
What Quality Information Will I Receive?
Patients should ask about:
- Cellular identity
- Purity
- Viability
- Sterility
- Safety testing
- Potency or functional testing
- Batch documentation
Who Determines Candidacy and Follow-Up?
A cellular product should form only one part of a broader physician-led medical evaluation and follow-up process.
Patients comparing providers may also find our guide on how to choose a stem cell clinic in Mexico useful when evaluating laboratory quality, physician oversight, documentation, and patient follow-up.
Frequently Asked Questions About Dezawa MUSE Cells
Is “Desawa MUSE Cells” the Correct Spelling?
No.
The correct spelling is Dezawa MUSE cells when referring to Dr. Mari Dezawa.
“Desawa,” “Dazawa,” “De Sawa,” and “Desawa Mu cells” are common search variations.
Did Dr. Dezawa Discover MUSE Cells?
Her research group is credited with first identifying and describing the cell population in 2010.
However, later clinical products and commercial programs should still be identified separately.
Are All MUSE Cells Dezawa MuseCells®?
No.
MUSE cells is also a scientific term, while Dezawa MuseCells® is a licensed commercial designation.
An unaffiliated product should not use the trademark or imply that it belongs to the MuseCell Innovations ecosystem.
Does a Branded MUSE-Cell Product Guarantee the Best Clinical Outcome?
No.
A brand may communicate a defined commercial source or manufacturing network, but it does not guarantee an outcome for an individual patient.
Clinical decisions should also consider:
- Product documentation
- Medical appropriateness
- Evidence for the condition
- Administration route
- Physician oversight
- Follow-up
- Individual patient factors
Patients who want additional guidance on provider quality can also review the 7 signs of safe stem cell clinics in Mexico.
The Bottom Line
Dr. Dezawa’s contribution to MUSE-cell science should be recognized accurately.
At the same time, patients researching Dezawa MUSE cells should understand that several separate elements are involved:
- The scientific discovery
- The general MUSE-cell category
- The CL2020 research product
- The Dezawa MuseCells® commercial brand
- The manufacturing laboratory
- The treating clinic
- The specific clinical protocol
A familiar scientific or commercial name does not automatically answer questions about product quality, clinical evidence, or patient candidacy.
Clear terminology helps patients compare cellular therapy programs more accurately and reduces the risk of confusing background research with a specific commercial product.
Comparing MUSE Cell Programs in Mexico?
If you are comparing MUSE-cell programs in Mexico, Cellular Institute can review your diagnosis and explain the product documentation, laboratory process, current evidence boundaries, and proposed clinical plan before you decide whether to travel.
You can also schedule a discovery call to discuss your questions with our team.
Sources
- MuseCell Innovations. Description of the licensed Dezawa MuseCells® commercial ecosystem.
https://musecellinnovations.com/patients - Niizuma K, et al. Randomized placebo-controlled trial of CL2020 in subacute ischemic stroke.
https://pubmed.ncbi.nlm.nih.gov/37756573/ - Cellular Institute MUSE Cell Content Strategy, August 2026.